Survival curves for patients in Capecitabine and Capecitabine/HAI groups. HAI/Capecitabine group: n = 24, 8 live, 16 died, median survival time 18.5 months, follow-up 8–42 momths; Capecitabine group: n = 27, 7 live, 20 died, median survival time 13 months, follow-up 4–26 momths (P=0.0312).